Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Alden Doyle"'
Autor:
Matthew J. Bottomley, Paul R. Massey, Raj Thuraisingham, Alden Doyle, Swati Rao, Kristin P. Bibee, Jan Nico Bouwes Bavinck, Anokhi Jambusaria-Pahlajani, Catherine A. Harwood
Publikováno v:
Transplant International. 35
Cutaneous squamous cell carcinoma (CSCC) is a major cause of morbidity and mortality after organ transplant. Many patients subsequently develop multiple CSCC following a first CSCC, and the risk of metastasis and death is significantly increased comp
Autor:
Kranthikiran Earasi, John Mihaltses, Jamie L. W. Kennedy, Swati Rao, Laura Holsten, Sula Mazimba, Alden Doyle, Andrew D. Mihalek
Publikováno v:
Clinical Transplantation. 36
Pulmonary hypertension (PH) is prevalent in those with end-stage kidney disease (ESKD) and poses a barrier to kidney transplant due to its association with poor outcomes. Studies examining these adverse outcomes are limited and often utilize echocard
Autor:
Gregory Malat, Meera N. Harhay, Sindhura Talluri, Alden Doyle, Karthik Ranganna, Dong Heun Lee, Suzanne M. Boyle, Tiffany E. Bias
Publikováno v:
Experimental and Clinical Transplantation. 18:153-156
Objectives Infection is a common cause of morbidity and mortality after kidney transplant. Based on the well-documented successes of reducing infections with decolonization of patients in intensive care units, we began a universal immediate posttrans
Autor:
Jeanne, Kamal, Alden, Doyle
Publikováno v:
Handbook of experimental pharmacology. 272
Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successful allotransplantation. Herein, we review the key immunosuppressive agent classes used for kidney transplant, highlig
Autor:
Gregory Malat, Rahul M. Jindal, Suzanne M. Boyle, Meera N. Harhay, Gary Xiao, Mysore S. Anil Kumar, Dong Heun Lee, Alden Doyle, Stephen Guy, Karthik Ranganna
Publikováno v:
American Journal of Kidney Diseases. 73:112-118
Hahnemann University Hospital has performed 120 kidney transplantations in human immunodeficiency virus (HIV)-positive individuals during the last 16 years. Our patient population represents ∼10% of the entire US population of HIV-positive kidney r
Publikováno v:
Transplantation. 101:974-979
BACKGROUND Ledipasvir-sofosbuvir is effective at eradicating hepatitis C virus (HCV) infection in the general population and in HCV-monoinfected kidney transplant recipients, but there are no data to guide its use in human immunodeficiency virus/HCV
Autor:
Nicole S, Evans, Ellen N, Pritchett, Krister, Jones, Alden, Doyle, Christina L, Chung, Herbert B, Allen, Carrie Ann R, Cusack
Publikováno v:
Cutis. 103(2)
Cutaneous gummatous tuberculosis (TB) is an uncommon subtype of cutaneous TB that can be seen in notably immunocompromised individuals. We report a case of cutaneous gummatous TB in an immunosuppressed kidney transplant patient. A 60-year-old Cambodi
Autor:
David A. Sass, Alden Doyle
Publikováno v:
Medical Clinics of North America. 100:435-448
This article describes the evolution of solid organ kidney and liver transplantation and expounds on the challenges and successes that the early transplant researchers and clinicians encountered. The article highlights the surgical pioneers, delves i
Publikováno v:
Transplant Infectious Disease. 18:155-159
Despite clear consensus and strong recommendations, vaccination rates of kidney transplant (KT) recipients have remained below targets. As vaccination is most effective if it is given prior to transplantation and the initiation of immunosuppression,
Autor:
J. A. Davis, K. H. Taylor, T. M. Daly, H. N. Neil, S. M. Tlusty, Darren Stewart, P. C. Camp, R. S. Brown, David K. Klassen, Alden Doyle
Publikováno v:
American Journal of Transplantation. 15:3123-3133
Analysis and dissemination of transplant patient safety data are essential to understanding key issues facing the transplant community and fostering a "culture of safety." The Organ Procurement and Transplantation Network's (OPTN) Operations and Safe